LISDEXAMFETAMINE DIMESYLATE | N021977 | TAKEDA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Takeda Pharmaceutical Company Limited et al v. Norwich Pharmaceuticals, Inc. et al 18 patentsANDA 214547lisdexamfetamine dimesylate | D. Del. | 2020-07-16 | Terminated 2020-10-30 | — |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al 16 patentsANDA 202835lisdexamfetamine dimesylate | D.N.J. | 2012-02-02 | Terminated 2012-06-28 | — |
Shire LLC et al v. Watson Laboratories Inc 3 patentsANDA 202818lisdexamfetamine dimesylate | D.N.J. | 2012-01-05 | Terminated 2014-04-09 | — |
SHIRE LLC et al v. ACTAVIS ELIZABETH LLC et al 16 patentsANDA 202802lisdexamfetamine dimesylate | D.N.J. | 2011-07-14 | Terminated 2011-12-09 | — |
Shire LLC et al v. Watson Laboratories Inc 3 patentsANDA 202818lisdexamfetamine dimesylate | C.D. Cal. | 2011-07-06 | Terminated 2012-01-04 | — |
SHIRE LLC et al v. AMNEAL PHARMACEUTICALS, LLC 15 patentsANDA 202830lisdexamfetamine dimesylate | D.N.J. | 2011-06-30 | Terminated 2014-07-22 | — |
| D.N.J. | 2011-06-30 | Terminated 2011-12-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.